PETS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines

03
Prix $1.36
Capitalisation Boursière (MRQ) $29M
P/E (TTM) -1.0
BPA (TTM) $-1.37
Revenu (TTM) $169M
Rendement div. 0.07%
ROE (TTM) -78.6%
Fourchette 52 semaines $1–$4

PETS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue

04
fourchette
barres

La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.

À propos de PetMed Express, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia

05 · wikidata

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Business model

PetMed Express is an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements. It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet medication.

History

Petmed Express was founded in Florida in 1996 by Marc Puleo. Puleo was an anesthesiologist who wanted to open a mail-order business for human prescriptions that also sold pet accessories. He shifted his focus to pet medicines due to Merck already heavily controlling the human prescription market. The company initially grew through word of mouth, television commercials, and its catalogs.

Its stock was traded on the OTC Bulletin Board under the symbol PETS from September 1997 until March 2000; in March 2000 the company began the process of becoming listed on the National Quotation Bureau Electronic Quotation Service and became responsible for reporting to the SEC.

Until 2002 PetMed Express and a company called Savemax Inc. operated in the same premises, shared staff, and operated under the same pharmacy licenses. According to the lawyer for both companies, Savemax was formed because of "a concern over PetMed's liability, and whether it [would] continue." From 1999 to 2002, PetMed Express and SaveMax were charged with violating the pharmaceutical law in several states. In one instance it was fined by the Environmental Protection Agency for selling drugs in metric doses, and has also received a warning letter from the FDA for selling misbranded drugs. In 1999, PetMed Express settled charges with the Florida Pharmacy Board for selling drugs that did not have prescriptions, false advertising, poor record keeping, and not labelling drugs correctly.

In addition to pet medications, PetMed Express also sold pet accessories such as leashes. In 2000, Tricon Holdings invested $2 million into the company. The company also hired Menderes Akdag as CEO in 2001. It discontinued 5,000 products and began focusing strictly on medicine-related items.

In 2002, PetMed Express and Savemax were fined by the EPA for selling prescription drugs illegally. The drugs were made by Novartis for sale in Europe and Australia and the doses and labelling were not FDA-approved. Also in 2002, PetMed Express, this time with Savemax, the company reached a settlement with the Florida Pharmacy Board for contracting with veterinarians to write prescriptions for animals they had never examined. The Florida board provided information to national boards and encouraged other state boards to take actions against veterinarians who had worked with PetMed Express to provide prescriptions for animals they had not examined. In the same year, the company settled similar charges in Ohio. In November 2002, the pharmacy board in Texas filed a lawsuit charging PetMed Express with dispensing veterinary drugs without prescriptions. The case was settled in 2006 with a $50,000 fine and three years' probation.

In 2004 a securities class action lawsuit was filed against the company, claiming that the company was not candid about the difficulty in getting prescriptions authorized by veterinarians. In 2005, the lawsuits were voluntarily dismissed by the plaintiffs. Puleo stepped down from executive leadership with the company the same year. Another shareholder lawsuit was filed against the company in 2018, claiming that it marketed dangerous animal drugs to humans. The lawsuit was later dismissed by plaintiffs after investigation of the claims.

As announced by PetMed Express Inc. in a regulatory filing published on Friday, June 4, 2021, Menderes Akdag, chief executive officer, leaves the online pet pharmacy after around 20 years in the role. PetMed said: “On May 28, 2021, the Board of Directors of PetMed Express, Inc. (the “Company”) notified Menderes Akdag, President and Chief Executive Officer, that the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021 in accordance with the scheduled end date of the agreement. The Company has presented a proposal to Mr. Akdag regarding the continuation of his role as President and Chief Executive Officer for a transition period following July 30, 2021 until a new CEO is appointed.” Matthew N. Hulett, the former president of language learning giant Rosetta Stone, was named CEO and president effective August 30, 2021. Hulett entered into a three-year employment agreement with PetMed Express at a $500,000 base salary per year. He also received 90,000 shares of restricted stock and 510,000 shares of performance restricted stock.

In April 2022, the company signed a partnership with Vetster, a telehealth veterinary company. As part of the agreement, PetMeds will be the exclusive eCommerce provider of Vetster medications, and Vetster will be the exclusive provider of telehealth services to PetMeds customers.

In 2023, PetMed partnered with Pumpkin Pet Insurance a pet insurance provider. In 2025, PetMed launched PetHealthMD a pet care insurance provider.

Recognition

The company was picked 4th among Forbes magazine's 200 Best Small Business Companies in 2006 and number 6 in 2007. BusinessWeek named PetMed Express number 27 of its top 100 "Hot Growth Companies" in 2006.

== References ==

Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗

Wikidata ↗

secteurRetail industrieRetail employés189 paysUS

Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA

06
Revenu$179M
2018-03-31 → 2026-03-31
BPA$-2.74
2018-03-31 → 2026-03-31
Flux de trésorerie libre$-33M
2018-03-31 → 2026-03-31
Marge nette-17.3%
2018-03-31 → 2026-03-31
Valorisation et Ratios 07–12

Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?

Métrique Tendance sur 5 ans PETS moyenne 5 ans Médiane des pairs Verdict
P/E (TTM) -1.0moyenne 5 ans ≈9.3 ≈9.3 · ·
P/S (TTM) 0.2moyenne 5 ans ≈0.3 ≈0.3 0.2 Juste valeur
P/B (MRQ) 1.3moyenne 5 ans ≈1.2 ≈1.2 · ·
Cours / FCF (TTM) -1.1moyenne 5 ans ≈-247.6 ≈-247.6 · ·
Cours / Flux de trésorerie (TTM) -1.2moyenne 5 ans ≈13.4 ≈13.4 · ·
Cours / Actif net tangible (MRQ) 1.7moyenne 5 ans ≈2.2 ≈2.2 · ·

La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.

valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane

Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans

13
Rendement du Dividende0.07%
Ratio de distribution-0.04%
Paiement annualisé≈$1.20Payé trimestriellement
Date ex-dividendeMontantDeviseRendement
Aoû 11, 2023$0,30USD≈9.4%
Jui 5, 2023$0,30USD≈8.2%
Fév 16, 2023$0,30USD≈6.1%
Nov 17, 2022$0,30USD≈6.3%
Aoû 11, 2022$0,30USD≈5.4%
Mai 19, 2022$0,30USD≈5.9%
Fév 4, 2022$0,30USD≈5.0%
Nov 5, 2021$0,30USD≈3.8%
Aoû 5, 2021$0,30USD≈4.0%
Mai 13, 2021$0,30USD≈4.1%
Jan 29, 2021$0,28USD≈2.9%
Nov 6, 2020$0,28USD≈3.7%
Jul 30, 2020$0,28USD≈3.5%
Mai 14, 2020$0,28USD≈3.4%
Jan 31, 2020$0,27USD≈4.3%
Nov 1, 2019$0,27USD≈4.7%
Aoû 1, 2019$0,27USD≈6.7%
Mai 16, 2019$0,27USD≈5.5%
Fév 1, 2019$0,27USD≈4.6%
Nov 2, 2018$0,27USD≈3.7%

Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats

14
Taux de battement 0.00%
Surprise Moyenne -674.5%
Prochain rapport Nov 11, 2026
PériodeRapportEPS ActualBPA est.Surprise
31 mars 2027 Aoû 13, 2026 $-0.28 $0.12 -328.8%
31 décembre 2026 Jui 2, 2026 $-0.19 $-0.18 -3.5%
30 juin 2026 Aoû 13, 2026 $-0.28 $0.12 -328.8%
31 mars 2026 $-0.19 $-0.18 -3.5%
31 décembre 2025 $-0.50 $-0.06 -717.0%
30 juin 2025 $-1.65 $-0.07 -2210.9%
31 mars 2025 $-0.56 $-0.05 -1129.2%
31 décembre 2024 $-0.03 $-0.01 —

Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie

15
Compte de résultat 16
Métrique Tendance 202620252024202320222021202020192018201720162015
Revenue $179M$227M$274M$248M$272M$304M$284M$283M$274M$249M$235M·
Cost of Revenue ·$158M$189M$171M$195M$219M$203M$188M$176M$170M$158M·
Gross Profit $50M$69M$85M$77M$77M$84M$81M$95M$98M$79M$76M·
SG&A Expense $51M$39M$55M$42M$31M$30M$25M$25M$24M$23M$21M·
Operating Expenses $109M$71M$93M$70M$53M$54M$50M$49M$46M$42M$44M·
Operating Income $-59M$-2M$-8M$6M$24M$31M$31M$46M$52M$37M$32M·
Interest Income ···$2M$335.0K$314.0K$2M$2M$658.0K$141.0K$190.0K·
Other Non-op $803.0K$758.0K$1M$944.0K$1M$1M$1M$1M$995.0K$300.0K$63.0K·
Pretax Income $-57M$-587.0K$-6M$7M$24M$31M$34M$49M$54M$38M$33M·
Income Tax $-73.0K$6M$1M$2M$5M$7M$8M$11M$17M$14M$12M·
Net Income $-57M$-6M$-7M$5M$19M$24M$26M$38M$37M$24M$21M·
EPS (Basic) $-2.74$-0.30$-0.37$0.25$0.93$1.19$1.29$1.84$1.83$1.18$1.02·
EPS (Diluted) $-2.74$-0.30$-0.37$0.25$0.92$1.19$1.29$1.84$1.82$1.17$1.02·
Shares (Basic) 20,921,36120,596,02220,395,95920,274,78620,175,93020,060,00020,041,00020,461,00020,346,00020,232,00020,124,000·
Shares (Diluted) 20,921,36120,596,02220,395,95920,339,00220,357,82020,119,00020,055,00020,491,00020,433,00020,378,00020,254,000·
EBITDA $-49M$6M$-1M$6M$26M$38M$31M$46M$52M···
Bilan 23
Métrique Tendance 202620252024202320222021202020192018201720162015
Cash & Equivalents $21M$55M$55M$104M$111M$119M$104M$101M$78M$59M$38M$36M
Receivables $2M$2M$3M$2M$2M$3M$4M$3M$2M$2M··
Inventory $14M$16M$29M·········
Prepaid Expense $6M$5M$6M$5M$5M$5M$4M$1M$882.0K$1M··
Current Assets $44M$79M$94M$130M$151M$161M$129M$126M$105M$82M··
PP&E (Net) $26M$29M$27M$26M$24M$25M$25M$27M$29M$30M··
PP&E (Gross) $58M$54M$47M$41M$36M$36M$36M$36M$35M$34M··
Accum. Depreciation $32M$25M$20M$15M$12M$10M$11M$8M$6M$4M··
Goodwill $0$27M$27M$0········
Intangibles $5M$8M$11M$860.0K$860.0K$860.0K$860.0K$860.0K$860.0K$860.0K··
Total Assets $81M$149M$170M$167M$180M$187M$155M$154M$135M$113M··
Accounts Payable $21M$24M$37M$25M$28M$40M$20M$16M$15M$15M··
Current Liabilities $52M$63M$72M$58M$56M$45M$24M$19M$18M$18M··
Capital Leases $42.0K$535.0K$995.0K$0········
Deferred Tax $175.0K$263.0K$0$3M$0$1M$970.0K$1M····
Other Non-current Liabilities ···$0$0·······
Total Liabilities $52M$64M$73M$58M$56M$46M$25M$20M$19M$19M··
Common Stock $21.0K$21.0K$21.0K$21.0K$21.0K$20.0K$20.0K$21.0K$21.0K$21.0K··
Paid-in Capital $20M$19M$25M$18M$12M$7M$4M$12M$9M$7M··
Retained Earnings $9M$67M$72M$92M$112M$134M$126M$122M$106M$87M··
Stockholders' Equity $29M$85M$97M$110M$123M$125M$120M$135M$116M$93M$83M$75M
Liabilities + Equity $81M$149M$170M$167M$180M$187M$155M$154M$135M$113M··
Shares Outstanding 21,385,63820,657,00021,148,00021,084,00020,979,00020,269,00020,166,00020,674,00020,601,00020,526,000··
Flux de trésorerie 15
Métrique Tendance 202620252024202320222021202020192018201720162015
D&A $9M$7M$7M$4M$3M·······
Stock-based Comp $1M$-7M$7M$7M$5M$3M$3M$3M$3M$2M$2M·
Deferred Tax $-88.0K$5M$292.0K$-2M$-846.0K$-1M$-151.0K$125.0K$-92.0K$2M$-23.0K·
Amort. of Intangibles $2M$2M$2M$0········
Other Non-cash $18M$5M$-2M·········
Operating Cash Flow $-28M$5M$4M$28M$18M$40M$39M$45M$37M$47M$21M·
CapEx $5M$5M$5M$5M$2M$2M$2M$620.0K$703.0K$11M$20M·
Investing Cash Flow $-5M$-5M$-41M$-10M$-2M$-2M$-2M$-620.0K$-703.0K$-11M$-4M·
Stock Repurchased ····$0$0$11M$0····
Net Stock Activity ····$0$0$-11M·····
Dividends Paid $21.0K$181.0K$12M$25M$24M$23M$22M$22M$17M$16M$15M·
Financing Cash Flow $-299.0K$-181.0K$-12M$-25M$-24M$-23M$-33M$-22M$-17M$-16M$-15M·
Net Change in Cash $-33M$-576.0K$-49M$-7M$-8M$15M$3M$23M$19M$21M$2M·
Taxes Paid $52.0K$525.0K$130.0K$4M$6M$10M······
Free Cash Flow $-33M$-395.0K$-194.0K$23M$17M$38M$37M$45M$37M···
Rentabilité 8
Métrique Tendance 202620252024202320222021202020192018201720162015
Gross Margin 28.1%30.5%28.0%27.6%28.6%29.1%··35.7%···
Operating Margin -32.8%-0.67%-2.9%2.4%9.4%12.2%··19.0%···
Net Margin -32.0%-2.8%-2.7%2.0%7.7%9.9%··13.6%···
Pretax Margin -32.0%-0.26%-2.2%2.9%9.9%12.7%··19.7%···
EBITDA Margin -27.5%2.4%-0.39%2.4%9.4%12.2%··19.0%···
ROA -49.8%-3.9%-4.4%·11.6%17.8%16.7%26.1%30.1%···
ROE -100.4%-6.9%-7.2%·15.8%23.4%19.5%30.1%35.7%···
ROIC -202.5%-19.2%-10.0%·14.1%20.8%18.2%26.3%31.2%···
Liquidité et Solvabilité 2
Métrique Tendance 202620252024202320222021202020192018201720162015
Current Ratio 0.81.31.3·4.53.65.36.85.8···
Quick Ratio 0.40.90.8·3.42.74.45.54.4···
Efficacité 3
Métrique Tendance 202620252024202320222021202020192018201720162015
Asset Turnover 1.61.41.7·1.51.8··2.2···
Inventory Turnover ·7.1··········
Receivables Turnover 84.781.1111.9·121.596.2··133.6···
Par action 6
Métrique Tendance 202620252024202320222021202020192018201720162015
Book Value / Share $1.35$4.12$4.57·$6.78$6.97$6.45$6.51$5.62···
Revenue / Share $8.56$11.02$13.78$12.62$13.43$15.37··$13.40···
Cash Flow / Share $-1.36$0.23$0.21$1.37$0.91$1.99$1.94$2.20$1.83···
Cash / Share $1.00$2.65$2.61·$5.29$5.86$5.15$4.86$3.78···
Dividend / Share $0.00$0.00$0.60$1.20$1.20$1.12$1.08$1.06$0.85$0.76$0.72·
EPS (TTM) $-2.74$-0.30$-0.37$0.25$0.92$1.19$1.29$1.84$1.82$1.17$1.02$0.80
Taux de croissance 6
Métrique Tendance 202620252024202320222021202020192018201720162015
Revenue YoY -21.1%-17.2%10.7%-9.1%-10.3%·······
Revenue CAGR 3Y -10.2%-5.9%-3.4%·········
Revenue CAGR 5Y -10.0%···········
EPS YoY ···-72.8%-22.7%·······
Net Income YoY ···-72.5%-21.8%·······
Dividends Paid CAGR 5Y -75.3%···········
Valorisation (TTM) 13
Métrique Tendance 202620252024202320222021202020192018201720162015
Revenue TTM $179M$227M$274M$248M$272M$304M$284M$283M$274M$249M$235M$227M
Net Income TTM $-57M$-6M$-7M$5M$19M$24M$26M$38M$37M$24M$21M$17M
Market Cap $49M$87M$101M·$541M$713M$580M$471M$860M···
P/E -0.8-14.0-12.965.028.029.622.312.422.917.217.620.6
P/S 0.30.40.4·2.02.32.01.73.1···
P/B 1.71.01.0·3.85.04.53.57.4···
P / Tangible Book 2.11.71.73.14.45.7······
P / Cash Flow -1.718.323.5·29.317.814.910.423.0···
P / FCF -1.5-219.1-522.2·32.318.915.910.623.5···
Dividend Yield 0.04%0.21%12.3%·4.5%3.2%3.8%4.7%2.0%···
Earnings Yield -120.2%-7.2%-7.7%1.5%3.6%3.4%4.5%8.1%4.4%5.8%5.7%4.8%
Payout Ratio -0.04%-2.9%-166.6%477.4%115.6%74.1%84.3%58.1%46.9%···
Annual Payout $21.0K$181.0K$12M$25M$24M$23M$22M$22M$17M$16M$15M·

Période la plus récente à gauche · valeurs nulles affichées comme ·

États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années

16
Métrique 2026-03-312025-03-312024-03-312023-03-312022-12-31
Revenu $179M $227M $274M $248M ·
Marge Brute % 28.1% 30.5% 28.0% 27.6% ·
Marge d'exploitation % -32.8% -0.67% -2.9% 2.4% ·
Résultat net $-57M $-6M $-7M $5M ·
BPA dilué $-2.74 $-0.30 $-0.37 $0.25 ·

Détenteurs institutionnels (13F) 53 déclarants · $11.9M total · Au 30 juin 2026

17

Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.

Détenteurs 53
Valeur détenue $11.9M
Nouvelles positions 10
Positions clôturées 8
Activité institutionnelle — Q2 2026 vs trimestre précédent
Nouvelles positions Positions clôturées Augmenté Diminué Variation nette des actions
10 (0 vs T. préc.) 8 (-2 vs T. préc.) 9 (-1 vs T. préc.) 18 (+2 vs T. préc.) -1.3M

Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.

Institution Valeur Actions % de 13F suivies Type
VANGUARD GROUP INC $3 084 028 963 759 26,00% Actions
RENAISSANCE TECHNOLOGIES LLC $2 171 962 1 131 230 18,31% Actions
VANGUARD CAPITAL MANAGEMENT LLC $1 588 602 827 397 13,39% Actions
BlackRock, Inc. $1 091 050 568 255 9,20% Actions
FEDERATED HERMES, INC. $407 367 212 170 3,43% Actions
GEODE CAPITAL MANAGEMENT, LLC $391 947 204 075 3,30% Actions
STEEL PARTNERS HOLDINGS L.P. $371 835 193 664 3,13% Actions
UBS Group AG $265 594 138 330 2,24% Actions
BRIDGEWAY CAPITAL MANAGEMENT, LLC $232 412 121 048 1,96% Actions
Rangeley Capital, LLC $232 320 121 000 1,96% Actions
VANGUARD FIDUCIARY TRUST CO $212 124 110 481 1,79% Actions
STATE STREET CORP $201 932 105 173 1,70% Actions
Formidable Asset Management, LLC $195 056 85 551 1,64% Actions
Empowered Funds, LLC $158 108 82 348 1,33% Actions
TUDOR INVESTMENT CORP ET AL $156 301 81 407 1,32% Actions
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $152 646 79 503 1,29% Actions
CITADEL ADVISORS LLC $142 324 74 127 1,20% Actions
DIMENSIONAL FUND ADVISORS LP $115 811 60 353 0,98% Actions
UMB Bank, n.a. $115 200 60 000 0,97% Actions
SUSQUEHANNA INTERNATIONAL GROUP, LLP $91 647 47 733 0,77% Actions
NORTHERN TRUST CORP $81 893 42 653 0,69% Actions
XTX Topco Ltd $80 511 41 933 0,68% Actions
CIBC Private Wealth Group LLC $75 300 30 000 0,63% Actions
SIMPLEX TRADING, LLC $47 702 24 845 0,40% Actions
IMC-Chicago, LLC $44 014 22 924 0,37% Actions
TUDOR INVESTMENT CORP ET AL $29 568 15 400 0,25% Option d'achat
Jain Global LLC $26 148 13 619 0,22% Actions
AMERICAN CENTURY COMPANIES INC $24 712 12 871 0,21% Actions
MORGAN STANLEY $22 282 11 604 0,19% Actions
BNP PARIBAS FINANCIAL MARKETS $17 637 9 186 0,15% Actions
Vanguard Global Advisers, LLC $15 590 8 120 0,13% Actions
OSAIC HOLDINGS, INC. $6 772 3 527 0,06% Actions
SBI Securities Co., Ltd. $2 148 1 119 0,02% Actions
Bank & Trust Co $2 054 901 0,02% Actions
HARBOUR INVESTMENTS, INC. $1 037 540 0,01% Actions
Accredited Wealth Management, LLC $1 004 5 636 0,01% Actions
Allworth Financial LP $949 494 0,01% Actions
MCF Advisors LLC $768 400 0,01% Actions
JONES FINANCIAL COMPANIES LLLP $730 415 0,01% Actions
Ascentis Independent Advisors $683 356 0,01% Actions
WELLS FARGO & COMPANY/MN $577 300 0,00% Actions
ROTHSCHILD INVESTMENT LLC $480 250 0,00% Actions
Tower Research Capital LLC (TRC) $323 168 0,00% Actions
Farther Finance Advisors, LLC $290 151 0,00% Actions
PRICE T ROWE ASSOCIATES INC /MD/ $250 129 933 0,00% Actions
FMR LLC $115 60 0,00% Actions
Elevated Capital Advisors, LLC $96 50 0,00% Actions
Caitong International Asset Management Co., Ltd $23 12 0,00% Actions
CITIGROUP INC $17 9 0,00% Actions
CoreCap Advisors, LLC $8 4 0,00% Actions

Afficher les 53 détenteurs institutionnels →

Activistes et détenteurs de 5%+ 2 participations

18

Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.

Déclarant Déposé Participation Statut Objectif Dépôt
SilverCape Investments Limited, Peter Kennedy ×3 dépôts 29 juin 2026 12,07% Amendement Investissement passif SEC
Diveroli Investment Group LLC, Kingbird Ventures LLC 11 février 2026 1,83% Dépôt initial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Initiés de la société 29 initiés · 8 dirigeants · 16 administrateurs

19
Dirigeant Rôle Dernière activité Actions détenues Achats 12m Ventes 12m Net 12m
Jeffrey Allen Willard CEO and President 28 septembre 2026 A 250 000 0 0 $0
Leslie C.G. Campbell Interim CEO and President 11 août 2026 A 145 000 0 0 $0
Sandra Yvette Campos CEO & President 30 avril 2025 S 578 524 0 0 $0
Menderes Akdag CEO & President 27 janvier 2021 S 337 800 0 0 $0
Douglas Krulik CAO and Interim CFO 26 juin 2026 A 102 500 0 0 $0
Robyn M. D'Elia Chief Financial Officer 27 septembre 2024 A 250 000 0 0 $0
Christine Chambers CFO 31 mai 2024 D 65 146 0 0 $0
Bruce S Rosenbloom Chief Financial Officer 30 juillet 2021 A 45 450 0 0 $0
Tamar Elkeles Administrateur 17 septembre 2026 A 49 923 0 0 $0
Peter Batushansky Administrateur 11 août 2026 A 91 928 0 0 $0
Justin L. Mennen Administrateur 11 août 2026 A 98 274 0 0 $0
Gian Fulgoni Administrateur 21 janvier 2026 D 132 299 0 0 $0
Leah Solivan Administrateur 30 octobre 2025 A 42 289 0 0 $0
Diana G Purcel Administrateur 8 août 2024 A 24 375 0 0 $0
Jodi Watson Administrateur 28 juillet 2022 A 18 880 0 0 $0
Peter Cobb Administrateur 28 juillet 2022 A 15 000 0 0 $0
Ronald J Korn Administrateur 30 juillet 2021 A 90 833 0 0 $0
Frank J Formica Administrateur 29 janvier 2021 S 55 000 0 0 $0
Robert C Schweitzer Administrateur 28 août 2020 S 95 834 0 0 $0
Marc Puleo MD Administrateur 16 août 2005 J 913 286 0 0 $0
SilverCape Investments Limited Détenteur de 10% 13 août 2025 P 2 579 696 0 0 $0
TRICON HOLDINGS LLC Détenteur de 10% 4 août 2006 S 2 284 000 0 0 $0
James Lacamp · 11 août 2026 A 90 421 0 0 $0
Jacqueline Paula Smith · 15 janvier 2025 A 28 099 0 0 $0
Mathew N Hulett · 29 avril 2024 D 103 850 0 0 $0
Mark Bradley Moseley JR · 11 décembre 2023 A 42 000 0 0 $0
Daniel Job Pingree · 17 mai 2023 A 22 000 0 0 $0
CRESLIN LTD · 4 août 2006 S 2 284 000 0 0 $0
Guven Kivilcim · 22 janvier 2004 S 1 310 300 0 0 $0

Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché

Détention d'ETF Détenu par 20 ETFs

20

Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.

Fonds Poids Unités Au Source
EWUS · iShares Trust 0,25% 37 222 SH 11 septembre 2026 Quotidien
ISVL · iShares Trust 0,17% 202 554 SH 11 septembre 2026 Quotidien
ISCF · iShares Trust 0,09% 216 018 SH 11 septembre 2026 Quotidien
IEUS · iShares Trust 0,07% 45 419 SH 11 septembre 2026 Quotidien
PDN · Invesco Exchange-Traded Fund Trust … 0,05% 58 613 SH 2 octobre 2026 Quotidien
SCZ · iShares Trust 0,03% 1 496 647 SH 11 septembre 2026 Quotidien
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0,03% 1 566 925 SH 19 août 2026 Quotidien
WSML · iShares Trust 0,01% 26 193 SH 11 septembre 2026 Quotidien
VGK · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 1 056 528 SH 19 août 2026 Quotidien
IEUR · iShares Trust 0,01% 291 699 SH 11 septembre 2026 Quotidien
IWC · iShares Trust 0,01% 51 213 SH 11 septembre 2026 Quotidien
IEFA · iShares Trust 0,00% 3 372 753 SH 11 septembre 2026 Quotidien
IDEV · iShares Trust 0,00% 546 389 SH 11 septembre 2026 Quotidien
IXUS · iShares Trust 0,00% 684 652 SH 11 septembre 2026 Quotidien
VXF · VANGUARD INDEX FUNDS 0,00% 211 088 SH 19 août 2026 Quotidien
VTI · VANGUARD INDEX FUNDS 0,00% 602 795 SH 19 août 2026 Quotidien
VXUS · VANGUARD STAR FUNDS 0,00% 6 557 275 SH 19 août 2026 Quotidien
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 341 189 SH 19 août 2026 Quotidien
VEA · VANGUARD TAX-MANAGED FUNDS 0,00% 4 366 658 SH 19 août 2026 Quotidien
VSGX · VANGUARD WORLD FUND 0,00% 78 854 SH 19 août 2026 Quotidien

PETS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse

21
notation · 6 analystes VENTE
Objectif médian $1.40 +2,9%
0 0,0% Achat fort
0 0,0% Achat
2 33,3% Conserver
2 33,3% Vente
2 33,3% Vente forte

Objectif de cours à 12 mois

1 analystes · 2026-10-01

Objectif moyen $1.40 +2,9%

Bas$1.40 Moyenne$1.40 Haut$1.40

Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur

22

Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.

Ticker Capitalisation Boursière P/E Revenus Année/Année Marge Nette ROE Marge Brute
PETS $49M -0.8 -21.1% -32.0% -100.4% 28.1%
RENT · 3.7 7.7% 6.9% -16.9% ·
GROV $46M -3.2 -14.6% -6.7% 75.6% 53.7%
SPWH $52M -1.1 0.96% -4.1% -25.2% 30.9%
LESL $46M -0.2 -6.6% -19.1% 70.0% 35.4%
ULTA $27.83B 24.6 9.7% 9.3% 42.7% 39.1%

Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets

26

Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.

Votre sélection est enregistrée et vous suit sur tous les tickers.

Source : Dépôt SEC 10-Q le Aoû 13, 2026